Cancer Associated Thrombosis and Isoquercetin (CATIQ)
Public ClinicalTrials.gov record NCT02195232. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Placebo-controlled, Double-blind Phase II/III Trial of Oral Isoquercetin to Prevent Venous Thromboembolic Events in Cancer Patients.
Study identification
- NCT ID
- NCT02195232
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Jeffrey Zwicker, MD
- Other
- Enrollment
- 64 participants
Conditions and interventions
Conditions
Interventions
- Isoquercetin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2014
- Primary completion
- Nov 30, 2018
- Completion
- Oct 21, 2019
- Last update posted
- Mar 2, 2021
2015 – 2019
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| USC/Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | — |
| VA Northern California Health Care System | Sacramento | California | 95655 | — |
| VA Connecticut Healthcare System | West Haven | Connecticut | 06450 | — |
| Veterans Affair Medical Center | Washington D.C. | District of Columbia | 20422 | — |
| York Hospital-Oncology Treatment Center | York Village | Maine | 03909 | — |
| Boston VA Healthcare System | Boston | Massachusetts | 02130 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Mount Auburn Hospital | Waltham | Massachusetts | 02138 | — |
| Washington University in St. Louis | St Louis | Missouri | 63110 | — |
| Providence VA Medical Center | Providence | Rhode Island | 02908 | — |
| White River Junction VA Medical Center | White River Junction | Vermont | 05009 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02195232, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 2, 2021 · Synced May 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02195232 live on ClinicalTrials.gov.